Rainbow Biosciences, LLC - a division of Rainbow Coral Corp. (RBCC) - is a new company focused on identifying, developing and marketing the next generation of bioscience solutions for the healthcare and scientific communities.
The company reached a major milestone recently in acquiring a new equity interest in emerging biotech game-changer Nano3D Biosciences (n3D). Nano3D's incredible new product, the Bio-Assembler, will soon allow researchers to dramatically shorten the development timeline for advanced new drugs and treatments while generating massive returns to investors.
In partnering with n3D, RBCC is poised for explosive growth in the biotech market, becoming a major new source of cutting-edge innovation.
The company is exploring several other opportunities within this sector, creating a rare opportunity for investors to become part of a multi-billion dollar industry just as it begins to take off.
Market Data 
Markets 
AI
